Related Articles
Serum amyloid A, ferritin and carcinoembryonic antigen as biomarkers of severity in patients with COVID‑19
Increased serum IL‑41 associated with acute exacerbation of chronic obstructive pulmonary disease
The value of serum amyloid A for predicting the severity and recovery of COVID‑19
Levels of acute inflammatory biomarkers in advanced prostate cancer patients with α2-macroglobulin deficiency
Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis